Rachel Sharman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rachel Sharman has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Colin Alexander Espie
University of Oxford
4 shared publications - Simon David Kyle
John Radcliffe Hospital, NIHR Oxford Biomedical Research Centre, Oxford, UK
4 shared publications - Jason Gordon Ellis
Department of Psychology Northumbria University Newcastle upon Tyne UK
3 shared publications Andrew Farmer
Nuffield Department of Primary Care Health Sciences University of Oxford Oxford UK
2 shared publications- Celyne H. Bastien
Université Laval, School of Psychology and Centre de Recherche CERVO, Québec, Canada
2 shared publications David Ray
Sir Jules Thorn Sleep and Circadian Neuroscience Institute Nuffield Department of Clinical Neurosciences, University of Oxford Oxford UK
2 shared publications
Latest Publications
- Open Access
Insights from nine nights of self-applied, low-density sleep EEG during sleep restriction therapy: a proof-of-concept evaluation
Objectives: Self-applied, low-density EEG offers opportunities to examine sleep in the home environment, yet its feasibility during behavioural sleep interventions remains unexplored. This pilot study aimed to evaluate the feasibility and acceptability of a self-applied, low-density EEG device during sleep restriction therapy (SRT) and explore effects on sleep and affect. Methods: Seventeen adults with insomnia and depressive symptoms completed a 2-week baseline and 4 weeks of SRT. The primary outcome was the proportion of expected EEG recordings completed and scoreable. Secondary outcomes included clinical measures, sleep continuity (sleep diary, actigraphy), sleep architecture (low-density EEG for 9 nights), power spectral density, and affect. Data were analysed with linear mixed models. Cohen's d and 95% confidence intervals were reported. Results: Feasibility was demonstrated (92% of expected EEG nights completed). SRT was associated with reductions in insomnia severity, depressive symptoms, negative affect, and increases in positive affect. Robust improvements were observed across treatment in sleep continuity (SOL, WASO, SE) from diary, which were paralleled by actigraphy. EEG revealed reduced TIB, TST, N1, N2, REM sleep, and REM latency during week one. Reductions in EEG-derived TIB and N1 sleep were maintained at night 28. There were no reliable differences for spectral or spindle measures. Conclusions: These findings suggest that self-applied, low-density EEG during SRT is feasible, acceptable, and may capture sleep changes during treatment. They highlight the potential for multi-night monitoring of sleep interventions at home and elucidating mechanisms underlying therapeutic change.
Open AccessInsights from nine nights of self-applied, low-density sleep EEG during sleep restriction therapy: a proof-of-concept evaluation
Objectives: Self-applied, low-density EEG offers opportunities to examine sleep in the home environment, yet its feasibility during behavioural sleep interventions remains unexplored. This pilot study aimed to evaluate the feasibility and acceptability of a self-applied, low-density EEG device during sleep restriction therapy (SRT) and explore effects on sleep and affect. Methods: Seventeen adults with insomnia and depressive symptoms completed a 2-week baseline and 4 weeks of SRT. The primary outcome was the proportion of expected EEG recordings completed and scoreable. Secondary outcomes included clinical measures, sleep continuity (sleep diary, actigraphy), sleep architecture (low-density EEG for 9 nights), power spectral density, and affect. Data were analysed with linear mixed models. Cohen's d and 95% confidence intervals were reported. Results: Feasibility was demonstrated (92% of expected EEG nights completed). SRT was associated with reductions in insomnia severity, depressive symptoms, negative affect, and increases in positive affect. Robust improvements were observed across treatment in sleep continuity (SOL, WASO, SE) from diary, which were paralleled by actigraphy. EEG revealed reduced TIB, TST, N1, N2, REM sleep, and REM latency during week one. Reductions in EEG-derived TIB and N1 sleep were maintained at night 28. There were no reliable differences for spectral or spindle measures. Conclusions: These findings suggest that self-applied, low-density EEG during SRT is feasible, acceptable, and may capture sleep changes during treatment. They highlight the potential for multi-night monitoring of sleep interventions at home and elucidating mechanisms underlying therapeutic change.
- Open Access
- 15 February 2026
- Published by Wiley in Journal of Sleep Research
- Vol. 35 (5) , e70306
Sleep Improvement for Metabolic Health: A Feasibility Trial of a Digital Sleep Treatment in People With Insomnia and Non‐Diabetic Hyperglycaemia
Insomnia may play a causal role in type 2 diabetes (T2D). Addressing insomnia through cognitive behavioural therapy (CBTi) in people with non‐diabetic hyperglycaemia could potentially reduce the risk of progression to T2D. To inform a future randomised trial, we performed a feasibility study of digital CBT (dCBTi) in individuals at increased risk of T2D. Participants were identified from 10 primary care practices in the UK and given access to dCBTi. Outcomes were evaluated at baseline (Week‐0) and post‐treatment (Week‐11). Primary feasibility outcomes were ability to recruit and treatment engagement. We also quantified within‐group mean change (95% CI) in insomnia severity (Insomnia Severity Index), health‐related quality of life (EQ‐5D‐3L), depression (Center for Epidemiologic Studies Depression Scale), chronotype (reduced Morningness‐Eveningness Questionnaire), sleep (7‐day actigraphy and diary), continuous glucose monitoring (7‐days) and fasting blood metabolites (insulin, lipids, glucose and C‐reactive protein). The recruitment target was 20. Of 242 people completing screening, 36 were eligible and 24 were enrolled (age 65.5 ± 12.4 years, 70.8% female). Twenty‐three (96%) completed post‐intervention assessments. Treatment engagement was excellent (83.3% completed ≥ 4 sessions). The intervention was associated with a large reduction in insomnia severity [−4.7 (95% CI: −6.2 to −3.2), d = −1.4] and medium reduction in depressive symptoms [−2.7 (95% CI: −5.1 to −0.2), d = −0.5]. Sleep diary parameters tended to show greater improvement following intervention relative to actigraphy. There was evidence of a reduction in serum lactate, glycerol and triglycerides but no clear change in glucose or insulin. Results suggest a full trial is likely feasible and that people with NDH find the intervention acceptable and beneficial. Trial Registration: This trial was prospectively registered on the UKs clinical study registry, the ISRCTN (ISRCTN19682964, https://doi.org/10.1186/ISRCTN19682964 )
- 15 February 2026
- Published by Wiley in Journal of Sleep Research
- Vol. 35 (5) , e70306
Open AccessSleep Improvement for Metabolic Health: A Feasibility Trial of a Digital Sleep Treatment in People With Insomnia and Non‐Diabetic Hyperglycaemia
Insomnia may play a causal role in type 2 diabetes (T2D). Addressing insomnia through cognitive behavioural therapy (CBTi) in people with non‐diabetic hyperglycaemia could potentially reduce the risk of progression to T2D. To inform a future randomised trial, we performed a feasibility study of digital CBT (dCBTi) in individuals at increased risk of T2D. Participants were identified from 10 primary care practices in the UK and given access to dCBTi. Outcomes were evaluated at baseline (Week‐0) and post‐treatment (Week‐11). Primary feasibility outcomes were ability to recruit and treatment engagement. We also quantified within‐group mean change (95% CI) in insomnia severity (Insomnia Severity Index), health‐related quality of life (EQ‐5D‐3L), depression (Center for Epidemiologic Studies Depression Scale), chronotype (reduced Morningness‐Eveningness Questionnaire), sleep (7‐day actigraphy and diary), continuous glucose monitoring (7‐days) and fasting blood metabolites (insulin, lipids, glucose and C‐reactive protein). The recruitment target was 20. Of 242 people completing screening, 36 were eligible and 24 were enrolled (age 65.5 ± 12.4 years, 70.8% female). Twenty‐three (96%) completed post‐intervention assessments. Treatment engagement was excellent (83.3% completed ≥ 4 sessions). The intervention was associated with a large reduction in insomnia severity [−4.7 (95% CI: −6.2 to −3.2), d = −1.4] and medium reduction in depressive symptoms [−2.7 (95% CI: −5.1 to −0.2), d = −0.5]. Sleep diary parameters tended to show greater improvement following intervention relative to actigraphy. There was evidence of a reduction in serum lactate, glycerol and triglycerides but no clear change in glucose or insulin. Results suggest a full trial is likely feasible and that people with NDH find the intervention acceptable and beneficial. Trial Registration: This trial was prospectively registered on the UKs clinical study registry, the ISRCTN (ISRCTN19682964, https://doi.org/10.1186/ISRCTN19682964 )
- Open Access
- 29 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e78779
Generation of a Free-Living Ground-Truth Validation Dataset for Wearable Measures of Physical Activity, Sedentary Behavior, Sleep, and Heart Rate in Adults (OxWEARS): Protocol for a Cross-Sectional Study
Background: Wearable devices enable continuous measurement of physical activity, sedentary behavior, sleep, and heart rate under free-living conditions. However, most validation studies rely on small, homogeneous samples; are conducted under laboratory conditions; or lack gold standard ground-truth measurements, limiting the generalizability and accuracy of derived metrics. There is a pressing need for open-access, large-scale, free-living validation datasets that include multisensor data from diverse body locations and participant demographics to aid in model development. Objective: The Oxford Wearable ECG, Activity, Circadian Rhythm, and Sleep Validation Study (OxWEARS) aims to (1) validate accelerometer-based measurement of physical behaviors across 5 body sites against annotated camera data; (2) validate measurements of sleep and sleep staging from 5 different body sites against polysomnography; (3) validate wrist-worn photoplethysmography heart rate measurements against chest-worn electrocardiogram; and (4) generate a comprehensive, annotated, and anonymized dataset for open-access research use. Methods: This cross-sectional study will recruit approximately 160 adults (aged ≥40 years) stratified by age, sex, and BMI from the Oxford BioBank. Over 3 days and 4 nights, participants will wear sensors on the wrists, chest, hip, thigh, and ankle. Ground-truth measures will be obtained from a chest electrocardiogram patch for heart rate, a first-person camera for activity annotation, an ankle-worn accelerometer for step count, and at-home polysomnography for sleep. An under-mattress sensor will collect measures of sleep, respiration rate, and bedtime, and a subjective sleep diary will also be obtained. Signals from different wear locations will be compared against the ground truth using precision, recall, F 1 -score, κ, and agreement metrics. Results: Recruitment commenced in November 2024, with 15 participants enrolled by May 2025. Overall, 50% of eligible adults contacted were happy to consent to the study, with excellent compliance with the protocol observed to date. Data collection is ongoing and expected to conclude in 2026, with the final annotated dataset made publicly available as soon as possible thereafter. Conclusions: The OxWEARS study will generate an openly accessible dataset containing more than 10,000 annotated hours from a stratified sample of adults. This will directly support scalable, generalizable human activity recognition efforts, while also enabling robust development and benchmarking of wearable-derived health metrics.
- 29 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e78779
Open AccessGeneration of a Free-Living Ground-Truth Validation Dataset for Wearable Measures of Physical Activity, Sedentary Behavior, Sleep, and Heart Rate in Adults (OxWEARS): Protocol for a Cross-Sectional Study
Background: Wearable devices enable continuous measurement of physical activity, sedentary behavior, sleep, and heart rate under free-living conditions. However, most validation studies rely on small, homogeneous samples; are conducted under laboratory conditions; or lack gold standard ground-truth measurements, limiting the generalizability and accuracy of derived metrics. There is a pressing need for open-access, large-scale, free-living validation datasets that include multisensor data from diverse body locations and participant demographics to aid in model development. Objective: The Oxford Wearable ECG, Activity, Circadian Rhythm, and Sleep Validation Study (OxWEARS) aims to (1) validate accelerometer-based measurement of physical behaviors across 5 body sites against annotated camera data; (2) validate measurements of sleep and sleep staging from 5 different body sites against polysomnography; (3) validate wrist-worn photoplethysmography heart rate measurements against chest-worn electrocardiogram; and (4) generate a comprehensive, annotated, and anonymized dataset for open-access research use. Methods: This cross-sectional study will recruit approximately 160 adults (aged ≥40 years) stratified by age, sex, and BMI from the Oxford BioBank. Over 3 days and 4 nights, participants will wear sensors on the wrists, chest, hip, thigh, and ankle. Ground-truth measures will be obtained from a chest electrocardiogram patch for heart rate, a first-person camera for activity annotation, an ankle-worn accelerometer for step count, and at-home polysomnography for sleep. An under-mattress sensor will collect measures of sleep, respiration rate, and bedtime, and a subjective sleep diary will also be obtained. Signals from different wear locations will be compared against the ground truth using precision, recall, F 1 -score, κ, and agreement metrics. Results: Recruitment commenced in November 2024, with 15 participants enrolled by May 2025. Overall, 50% of eligible adults contacted were happy to consent to the study, with excellent compliance with the protocol observed to date. Data collection is ongoing and expected to conclude in 2026, with the final annotated dataset made publicly available as soon as possible thereafter. Conclusions: The OxWEARS study will generate an openly accessible dataset containing more than 10,000 annotated hours from a stratified sample of adults. This will directly support scalable, generalizable human activity recognition efforts, while also enabling robust development and benchmarking of wearable-derived health metrics.
- Open Access
Sleep improvement for metabolic health: A feasibility trial of a digital sleep treatment in people with insomnia and non-diabetic hyperglycaemia
Insomnia may play a causal role in type 2 diabetes (T2D). Addressing insomnia through cognitive behavioural therapy (CBTi) in people with non-diabetic hyperglycaemia could potentially reduce the risk of progression to T2D. To inform a future randomised trial, we performed a feasibility study of digital CBT (dCBTi) in individuals at increased risk of T2D. Participants were identified from ten primary care practices in the UK and given access to dCBTi. Outcomes were evaluated at baseline (week-0) and post-treatment (week-11). Primary feasibility outcomes were ability to recruit and treatment engagement. We also quantified within-group mean change (95%CI) in insomnia severity (Insomnia Severity Index), health-related quality of life (EQ-5D-3L), depression (Center for Epidemiologic Studies Depression Scale), chronotype (reduced Morningness-Eveningness Questionnaire), sleep (7-day actigraphy and diary), continuous glucose monitoring (7-days) and fasting blood metabolites (insulin, lipids, glucose, and C-reactive protein). The recruitment target was 20. Of 242 people completing screening, 36 were eligible, and 24 were enrolled (age 65.5±12.4 years, 70.8% female). Twenty-three (96%) completed post-intervention assessments. Treatment engagement was excellent (83.3% completed ≥4 sessions). The intervention was associated with a large reduction in insomnia severity [−4.7(95%CI:−6.2 to −3.2), d =−1.4] and medium reduction in depressive symptoms [−2.7(95%CI:−5.1 to −0.2), d =−0.5]. Sleep diary parameters tended to show greater improvement following intervention relative to actigraphy. There was evidence of a reduction in serum lactate, glycerol and triglycerides but no clear change in glucose or insulin. Results suggest a full trial is likely feasible and that people with NDH find the intervention acceptable and beneficial. Trial Registration: This trial was prospectively registered on the UKs clinical study registry, the ISRCTN ( ISRCTN19682964 , https://doi.org/10.1186/ISRCTN19682964 )
Open AccessSleep improvement for metabolic health: A feasibility trial of a digital sleep treatment in people with insomnia and non-diabetic hyperglycaemia
Insomnia may play a causal role in type 2 diabetes (T2D). Addressing insomnia through cognitive behavioural therapy (CBTi) in people with non-diabetic hyperglycaemia could potentially reduce the risk of progression to T2D. To inform a future randomised trial, we performed a feasibility study of digital CBT (dCBTi) in individuals at increased risk of T2D. Participants were identified from ten primary care practices in the UK and given access to dCBTi. Outcomes were evaluated at baseline (week-0) and post-treatment (week-11). Primary feasibility outcomes were ability to recruit and treatment engagement. We also quantified within-group mean change (95%CI) in insomnia severity (Insomnia Severity Index), health-related quality of life (EQ-5D-3L), depression (Center for Epidemiologic Studies Depression Scale), chronotype (reduced Morningness-Eveningness Questionnaire), sleep (7-day actigraphy and diary), continuous glucose monitoring (7-days) and fasting blood metabolites (insulin, lipids, glucose, and C-reactive protein). The recruitment target was 20. Of 242 people completing screening, 36 were eligible, and 24 were enrolled (age 65.5±12.4 years, 70.8% female). Twenty-three (96%) completed post-intervention assessments. Treatment engagement was excellent (83.3% completed ≥4 sessions). The intervention was associated with a large reduction in insomnia severity [−4.7(95%CI:−6.2 to −3.2), d =−1.4] and medium reduction in depressive symptoms [−2.7(95%CI:−5.1 to −0.2), d =−0.5]. Sleep diary parameters tended to show greater improvement following intervention relative to actigraphy. There was evidence of a reduction in serum lactate, glycerol and triglycerides but no clear change in glucose or insulin. Results suggest a full trial is likely feasible and that people with NDH find the intervention acceptable and beneficial. Trial Registration: This trial was prospectively registered on the UKs clinical study registry, the ISRCTN ( ISRCTN19682964 , https://doi.org/10.1186/ISRCTN19682964 )
- Open Access
- 13 March 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (10)
Is it time to revisit the scoring of slow wave (N3) sleep?
The use of a fixed electroencephalogram (EEG) amplitude threshold of 75 µV for labeling slow waves is a subject of ongoing discussion given EEG amplitude is known to vary with age and sex. This paper investigates the impact of this amplitude threshold on age- and sex-related trends in visually annotated slow wave sleep (SWS). Automated methods for labeling SWS using data-driven thresholds and amplitude- or frequency-based inputs are developed. Age- and sex-related trends in SWS derived from visual annotation and automated labeling are then compared across a cohort of 2913 participants from the Sleep Heart Health Study. In the selected cohort, males exhibit an age-related decrease in visually annotated SWS, which is preserved when using automated labeling. In contrast, females exhibit a mild age-related increase in visually annotated and amplitude-labeled SWS, but an age-related decrease in frequency-labeled SWS. Furthermore, using frequency-labeled SWS results in a reduction in SWS in females to a level comparable to that of males. Overall, the consistency of age-related trends in SWS in males between visual annotation and automated labeling, as well as the lack of consistency in these trends in females, is striking. Given that the 75 µV amplitude threshold was established using data acquired primarily from young males, these results suggest that observed sex-based differences in visually annotated SWS may be artifactual rather than physiological, and a result of the 75 µV amplitude criterion. This sex-related disparity highlights the need for the American Association of Sleep Medicine guidelines for scoring SWS to be reviewed and updated to provide equivalent performance for males and females.
- 13 March 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (10)
Open AccessIs it time to revisit the scoring of slow wave (N3) sleep?
The use of a fixed electroencephalogram (EEG) amplitude threshold of 75 µV for labeling slow waves is a subject of ongoing discussion given EEG amplitude is known to vary with age and sex. This paper investigates the impact of this amplitude threshold on age- and sex-related trends in visually annotated slow wave sleep (SWS). Automated methods for labeling SWS using data-driven thresholds and amplitude- or frequency-based inputs are developed. Age- and sex-related trends in SWS derived from visual annotation and automated labeling are then compared across a cohort of 2913 participants from the Sleep Heart Health Study. In the selected cohort, males exhibit an age-related decrease in visually annotated SWS, which is preserved when using automated labeling. In contrast, females exhibit a mild age-related increase in visually annotated and amplitude-labeled SWS, but an age-related decrease in frequency-labeled SWS. Furthermore, using frequency-labeled SWS results in a reduction in SWS in females to a level comparable to that of males. Overall, the consistency of age-related trends in SWS in males between visual annotation and automated labeling, as well as the lack of consistency in these trends in females, is striking. Given that the 75 µV amplitude threshold was established using data acquired primarily from young males, these results suggest that observed sex-based differences in visually annotated SWS may be artifactual rather than physiological, and a result of the 75 µV amplitude criterion. This sex-related disparity highlights the need for the American Association of Sleep Medicine guidelines for scoring SWS to be reviewed and updated to provide equivalent performance for males and females.
- Open Access
- 27 November 2023
- Published by Wiley in Journal of Sleep Research
- Vol. 33 (4) , e14094
Associations between self‐reported sleep, overnight memory consolidation, and emotion perception: A large‐scale online study in the general population
Summary: Experimental studies suggest that short or disrupted sleep impairs memory consolidation, mood, and perception of emotional stimuli. However, studies have chiefly relied on laboratory‐based study designs and small sample sizes. The aim of this fully online and pre‐registered study was to investigate the association between sleep and overnight memory consolidation, emotion perception, and affect in a large, self‐selected UK sample. A total of 1646 participants (473 completed) took part in an online study, where they completed a declarative (word‐pairs) memory task, emotion perception task (valence ratings of images), and rated their affect within 2 h of bed‐time. The following morning, participants reported on their state affect, sleep for the previous night, completed a cued recall task for the previously presented word‐pairs, rated the valence of previously viewed images, and completed a surprise recognition task. Demographic data and habitual sleep quality and duration (sleep traits) were also recorded. Habitual sleep traits were associated with immediate recall for the word‐pairs task, while self‐reported sleep parameters for the specific night were not associated with overnight memory consolidation. Neither habitual sleep traits, nor nightly sleep parameters were associated with unpleasantness ratings to negative stimuli or overnight habituation. Habitual poor sleep was associated with less positive and more negative affect, and morning affect was predicted by the specific night's sleep. This study suggests that overnight emotional processing and declarative memory may not be associated with self‐reported sleep across individuals. More work is needed to understand how findings from laboratory‐based studies extrapolate to real‐world samples and contexts.
- 27 November 2023
- Published by Wiley in Journal of Sleep Research
- Vol. 33 (4) , e14094
Open AccessAssociations between self‐reported sleep, overnight memory consolidation, and emotion perception: A large‐scale online study in the general population
Summary: Experimental studies suggest that short or disrupted sleep impairs memory consolidation, mood, and perception of emotional stimuli. However, studies have chiefly relied on laboratory‐based study designs and small sample sizes. The aim of this fully online and pre‐registered study was to investigate the association between sleep and overnight memory consolidation, emotion perception, and affect in a large, self‐selected UK sample. A total of 1646 participants (473 completed) took part in an online study, where they completed a declarative (word‐pairs) memory task, emotion perception task (valence ratings of images), and rated their affect within 2 h of bed‐time. The following morning, participants reported on their state affect, sleep for the previous night, completed a cued recall task for the previously presented word‐pairs, rated the valence of previously viewed images, and completed a surprise recognition task. Demographic data and habitual sleep quality and duration (sleep traits) were also recorded. Habitual sleep traits were associated with immediate recall for the word‐pairs task, while self‐reported sleep parameters for the specific night were not associated with overnight memory consolidation. Neither habitual sleep traits, nor nightly sleep parameters were associated with unpleasantness ratings to negative stimuli or overnight habituation. Habitual poor sleep was associated with less positive and more negative affect, and morning affect was predicted by the specific night's sleep. This study suggests that overnight emotional processing and declarative memory may not be associated with self‐reported sleep across individuals. More work is needed to understand how findings from laboratory‐based studies extrapolate to real‐world samples and contexts.
- Open Access
- 9 September 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (9) , 1220
Pre-Sleep Cognitive Arousal Is Unrelated to Sleep Misperception in Healthy Sleepers When Unexpected Sounds Are Played during Non-Rapid Eye Movement Sleep: A Polysomnography Study
Background: It is well-established that environmental noise can disrupt sleep, and cause a mismatch between subjective and objective sleep, which is known as “sleep misperception”. Naturalistic studies indicate that pre-sleep cognitive arousal and sleep misperception are associated in the context of noise. However, it is not known if this is the case when ecologically valid noises are specifically played during non-rapid eye movement (NREM) sleep, which is susceptible to noise-related disruption. The present study evaluated if pre-sleep cognitive arousal was associated with sleep misperception in healthy normal sleepers, when unexpected ecologically valid common nocturnal noises were played during NREM sleep. Methods: Eighteen healthy sleepers (Mage = 23.37 years, SDage = 3.21 years) participated. Sleep was measured objectively on three consecutive nights using polysomnography, in a sleep laboratory environment, and subjectively, through participant estimates of total sleep time (TST). Night 1 was a baseline night where no noises were played. On Night 2, noises, which were chosen to be representative of habitual nocturnal noises heard in home environments, were played to participants via in-ear headphones after 5 min of objective sleep. Results: Unexpectedly, habitual pre-sleep cognitive arousal was not associated with subjective–objective TST discrepancy on Night 2. Conclusions: These results suggest that in healthy sleepers, when ecologically valid noises are played unexpectedly during NREM sleep in an unfamiliar sleep laboratory environment the subjective experience of sleep is not associated with pre-sleep cognitive arousal, or negatively impacted by noise exposure.
- 9 September 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (9) , 1220
Open AccessPre-Sleep Cognitive Arousal Is Unrelated to Sleep Misperception in Healthy Sleepers When Unexpected Sounds Are Played during Non-Rapid Eye Movement Sleep: A Polysomnography Study
Background: It is well-established that environmental noise can disrupt sleep, and cause a mismatch between subjective and objective sleep, which is known as “sleep misperception”. Naturalistic studies indicate that pre-sleep cognitive arousal and sleep misperception are associated in the context of noise. However, it is not known if this is the case when ecologically valid noises are specifically played during non-rapid eye movement (NREM) sleep, which is susceptible to noise-related disruption. The present study evaluated if pre-sleep cognitive arousal was associated with sleep misperception in healthy normal sleepers, when unexpected ecologically valid common nocturnal noises were played during NREM sleep. Methods: Eighteen healthy sleepers (Mage = 23.37 years, SDage = 3.21 years) participated. Sleep was measured objectively on three consecutive nights using polysomnography, in a sleep laboratory environment, and subjectively, through participant estimates of total sleep time (TST). Night 1 was a baseline night where no noises were played. On Night 2, noises, which were chosen to be representative of habitual nocturnal noises heard in home environments, were played to participants via in-ear headphones after 5 min of objective sleep. Results: Unexpectedly, habitual pre-sleep cognitive arousal was not associated with subjective–objective TST discrepancy on Night 2. Conclusions: These results suggest that in healthy sleepers, when ecologically valid noises are played unexpectedly during NREM sleep in an unfamiliar sleep laboratory environment the subjective experience of sleep is not associated with pre-sleep cognitive arousal, or negatively impacted by noise exposure.
- Open Access
- 24 February 2022
- Published by MDPI AG in Clocks & Sleep
- Vol. 4 (1) , 88-99
Pre-Sleep Cognitive Arousal Is Negatively Associated with Sleep Misperception in Healthy Sleepers during Habitual Environmental Noise Exposure: An Actigraphy Study
Specific noises (e.g., traffic or wind turbines) can disrupt sleep and potentially cause a mismatch between subjective sleep and objective sleep (i.e., “sleep misperception”). Some individuals are likely to be more vulnerable than others to noise-related sleep disturbances, potentially as a result of increased pre-sleep cognitive arousal. The aim of the present study was to examine the relationships between pre-sleep cognitive arousal and sleep misperception. Sixteen healthy sleepers participated in this naturalistic, observational study. Three nights of sleep were measured using actigraphy, and each 15-s epoch was classified as sleep or wake. Bedside noise was recorded, and each 15-s segment was classified as containing noise or no noise and matched to actigraphy. Participants completed measures of habitual pre-sleep cognitive and somatic arousal and noise sensitivity. Pre-sleep cognitive and somatic arousal levels were negatively associated with subjective–objective total sleep time discrepancy (p < 0.01). There was an association between sleep/wake and noise presence/absence in the first and last 90 min of sleep (p < 0.001). These results indicate that higher levels of habitual pre-sleep arousal are associated with a greater degree of sleep misperception, and even in healthy sleepers, objective sleep is vulnerable to habitual bedside noise.
- 24 February 2022
- Published by MDPI AG in Clocks & Sleep
- Vol. 4 (1) , 88-99
Open AccessPre-Sleep Cognitive Arousal Is Negatively Associated with Sleep Misperception in Healthy Sleepers during Habitual Environmental Noise Exposure: An Actigraphy Study
Specific noises (e.g., traffic or wind turbines) can disrupt sleep and potentially cause a mismatch between subjective sleep and objective sleep (i.e., “sleep misperception”). Some individuals are likely to be more vulnerable than others to noise-related sleep disturbances, potentially as a result of increased pre-sleep cognitive arousal. The aim of the present study was to examine the relationships between pre-sleep cognitive arousal and sleep misperception. Sixteen healthy sleepers participated in this naturalistic, observational study. Three nights of sleep were measured using actigraphy, and each 15-s epoch was classified as sleep or wake. Bedside noise was recorded, and each 15-s segment was classified as containing noise or no noise and matched to actigraphy. Participants completed measures of habitual pre-sleep cognitive and somatic arousal and noise sensitivity. Pre-sleep cognitive and somatic arousal levels were negatively associated with subjective–objective total sleep time discrepancy (p < 0.01). There was an association between sleep/wake and noise presence/absence in the first and last 90 min of sleep (p < 0.001). These results indicate that higher levels of habitual pre-sleep arousal are associated with a greater degree of sleep misperception, and even in healthy sleepers, objective sleep is vulnerable to habitual bedside noise.
- 1 October 2021
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 17 (10) , 2129-2130
Factors influencing the discrepancy between self-reported and objective sleep: a missed opportunity?
The official peer-reviewed journal of the American Academy of Sleep Medicine.
- 1 October 2021
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 17 (10) , 2129-2130
Factors influencing the discrepancy between self-reported and objective sleep: a missed opportunity?
The official peer-reviewed journal of the American Academy of Sleep Medicine.
- 1 June 2020
- Published by Elsevier in Current Opinion in Physiology
- Vol. 15, 23-28
Adolescent sleep and school performance — the problem of sleepy teenagers
- 1 June 2020
- Published by Elsevier in Current Opinion in Physiology
- Vol. 15, 23-28
Adolescent sleep and school performance — the problem of sleepy teenagers